Inactive Instrument

Other languages Medical Prognosis Institute A/S Nasdaq Copenhagen

Equities

MPIT

DK0060732477

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Top Premarket Gainers	Apr. 12
Allarity Therapeutics to Implement 1-for-20 Reverse Stock Split	Apr. 04
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer	Mar. 27
Allarity Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 08
Allarity Therapeutics, Inc. Announces Termination of Marie Foegh as Chief Medical Officer	Mar. 04
Allarity Therapeutics, Inc. Announces Resignation of James G. Cullem as Member of the Board	Feb. 01
Allarity Therapeutics Announces Executive Changes	Dec. 12
Allarity Therapeutics, Inc. Announces Chief Executive Officer Changes	Dec. 11
Allarity Therapeutics, Inc. Announces Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP Companion Diagnostic	Dec. 05
Allarity Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Allarity Therapeutics Announces Positive Early Data from an Ongoing Clinical Trial, and External Partnering for Its DRP Technology	23-09-14
Top Premarket Gainers	23-08-31
Allarity Therapeutics, Inc. Announces the Publication of its Clinical Validation of a Novel Drug-Specific DRP-Companion Diagnostic for Dovitinib in the Peer-Reviewed Journal PLOS ONE	23-08-30
Allarity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Allarity Therapeutics, Inc. Announces Board Changes	23-08-11
Top Premarket Gainers	23-07-31
Allarity Therapeutics, Inc. and Detsamma Investments Pty. Ltd. Announce Collaboration to Support Clinical Development of Deflexifol? with DRP® Companion Diagnostics	23-07-31
Allarity Therapeutics and FivepHusion Announce Collaboration to Support Clinical Development of Deflexifol with DRP Companion Diagnostics	23-07-31
Allarity Therapeutics, Inc. Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives	23-07-24
Top Midday Decliners	23-07-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Medical Prognosis Institute A/S Nasdaq Copenhagen

Equities

MPIT

DK0060732477

Other languages

Filters